Although in the cumulative analysis the median RASSF1A expression level in PTC was comparable with expression in normal tissue (Figure 5b), the patient-matched analysis proved a significantly lower expression level also in this type of thyroid cancer (Figure 6a). The gene discussed is RASSF1; the disease is thyroid cancer.